Effective August 1, 2016, Zenith Epigenetics became a wholly owned subsidiary of Zenith Capital Corp.
Zenith Capital Corp., a biotechnology investment company, is a reporting issuer in all Provinces of Canada.
The following documents require Adobe Acrobat Reader, click to download.
